JAC Advance Access originally published online on May 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy 2004 54(1):173-177; doi:10.1093/jac/dkh282
JAC vol.54 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae
1 Service d'Hygiène Hospitalière et d'Epidémiologie Moléculaire, Centre Hospitalier Universitaire Jean Minjoz, Besançon, France; 2 Preventive Medicine Unit, Hospital Vega Baja, Orihuela, Spain
* Correspondence address. Service d'Hygiène Hospitalière, CHU Jean Minjoz, 25030 Besançon cedex, France. Tel: +33-3-81-66-82-86; Fax: +33-3-81-66-89-14; Email: daniel.talon{at}ufc-chu.univ-fcomte.fr
Objective: To investigate the potential correlation between the use of extended-spectrum cephalosporins (ESCs) and resistance to this antibiotic class among clinical isolates of Enterobacter cloacae in a university-affiliated hospital.
Materials and methods: Data on antimicrobial resistance and antimicrobial use concerning E. cloacae and ESCs were collected over a 4 year period. Various statistical tools were used to explore the potential relationship.
Results: From 1999 to 2002, the proportion of E. cloacae isolates resistant to ESCs increased from 24.3% to 29.6%. (P=0.04), and the quantity of ESCs prescribed and given did not change. Within the subclass constituted by first-line ESCs, the proportion of ceftriaxone increased from 64.3% to 77.6% and the proportion of cefotaxime decreased accordingly, from 35.7% to 22.4%. Statistical analyses showed that E. cloacae resistance to ESCs correlated with ceftriaxone use regardless of the other ESCs. For every defined daily dose of ceftriaxone per 1000 patient days used in our hospital, resistance of E. cloacae isolates to ESCs increased by 1.36%.
Conclusion: This study demonstrates a specific correlation between ceftriaxone use and the development of resistance in E. cloacae clinical isolates. The high biliary elimination of ceftriaxone compared with other ESCs may be responsible for a greater impact of this antibiotic on the digestive flora.
Keywords: E. cloacae , antibiotic resistance , ceftriaxone , cefotaxime , statistical analysis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Dong, H. Yan, and D. Wang Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China J. Antimicrob. Chemother., August 1, 2008; 62(2): 410 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hocquet, A. Muller, K. Blanc, P. Plesiat, D. Talon, D. L. Monnet, and X. Bertrand Relationship between Antibiotic Use and Incidence of MexXY-OprM Overproducers among Clinical Isolates of Pseudomonas aeruginosa Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1173 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. F. Goessens, J. W. Mouton, M. T. ten Kate, A. J. Bijl, A. Ott, and I. A. J. M. Bakker-Woudenberg Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection J. Antimicrob. Chemother., March 1, 2007; 59(3): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hocquet, P. Nordmann, F. El Garch, L. Cabanne, and P. Plesiat Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1347 - 1351. [Abstract] [Full Text] [PDF]
|
|